Primary Care Update for OB/GYNS

Abstracts from the 46th annual clinical meeting of the American College of Obstetricians and Gynecologists
pp. 145-145(1)

Asymptomatic bacteriuria in human immunodeficiency (HIV)-infected women
pp. 146-146(1)
Authors: Gottlieb D.D.; Fuhr A.; Hatch W.V.; Wright K.D.; Gugino L.; Russo T.; Wactawski-Wende J.; Goodnough S.L.; Tristram D.A.; Mylotte J.

Yield of postoperative fever evaluation
pp. 146-146(1)
Authors: Josman N.; Katz N.; Fanning J.; Neuhoff R.A.; Brewer J.E.; Castaneda T.; Marcotte M.P.; Jacobson R.L.

A prospective, randomized, clinical study to compare the clinical safety, effectiveness, and cost of oral ofloxacin/clindamycin vs intravenous clindamycin/gentamicin for the treatment of postpartum endomyometritis
pp. 146-147(2)
Authors: Gretz H.R.; Doering L.L.; Quinn J.; Raftopoulos M.; Nelson A.J.; Zwick D.E.; Pietrantoni M.; Goss S.; Gall S.A.

Simplified cesarean section: a strategic surgical approach to minimize postoperative infectious morbidity
pp. 147-147(1)
Authors: Kolakowsky S.A.; Pelosi M.A.; Pelosi M.A.

Single-dose antibiotic prophylaxis during cesarean section
pp. 147-148(2)
Authors: Malia K.B.; Raymond M.J.; Bewick K.C.; Bennett T.L.; Gugino L.; Cimino M.; Wactawski-Wende J.

Chorioamnionitis: the association between clinical and histological diagnosis
pp. 148-148(1)
Authors: Twigg A.R.; Cifu D.X.; Keyser-Marcus L.; Swartz Z.; Gugino L.J.; Buerger P.T.; Wactawski-Wende J.; Fisher J.

Febrile morbidity and hospital stay in high-risk cesarian section patients at a non-teaching hospital
pp. 148-148(1)
Authors: Cohen M.R.; Persad S.I.

Strategies to decrease costs associated with GBS prophylaxis in preterm gestations
pp. 148-149(2)
Authors: Nguyen T.; Guinn D.A.; Rodriguez A.; Mehendale R.; Quillen E.Q.; Albrecht L.M.

Rubella and pregnancy: failed prevention policies
pp. 149-149(1)
Authors: Figueroa R.; Reale A.; Tejani N.

Potential for routine concurrent determination of chlamydia and cervical abnormalities by single fluid-based sampling
pp. 149-150(2)
Authors: Lentrichia B.B.; Hecht S.S.; Lapen D.; Corkill M.K.

The association of asymptomatic bacterial vaginosis with upper genital tract infection
pp. 150-150(1)
Authors: Bennett B.B.; Clark P.; Riley P.; Hardt N.S.; Duff P.

Safety and efficacy comparison of two dosing regimens of MetroGel-Vaginal(R) in the treatment of bacterial vaginosis: a multicenter, randomized, single-blind, parallel comparison
pp. 150-150(1)
Authors: Soper D.E.; Livengood C.; Sheehan K.L.; Fenner D.E.; Martens M.G.; Nelson A.L.; Ismail M.; Thorp J.M.; Lappin M.; Fleury F.J.; Long B.J.; Blackwelder T.; Sweet R.L.; Sagov S.

Can a multimedia educational computer-based program on genital herpes teach patients about their disease?
pp. 151-151(1)
Authors: Wald A.; Stern J.O.; Skinner E.P.; Beutner K.; Conant M.A.; Tyring S.K.; Reitano M.V.; Davis G.

Percutaneous penetration of Aldara&unknown; cream, 5% during the topical treatment of genital and perianal warts
pp. 151-151(1)
Authors: Owens M.L.; Bridson W.E.; Smith S.L.; Myers J.A.; Fox T.L.; Wells T.M.

Mechanism of action of imiquimod 5% cream in the treatment of anogenital warts
pp. 151-152(2)
Authors: Tyring S.K.; Arany I.; Stanley M.A.; Stoler M.H.; Tomai M.A.; Miller R.L.; Owens M.L.; Smith M.H.

Assessment of vulvovaginal complaints: agreement between phone and office management
pp. 152-152(1)
Authors: Allen-Davis J.T.; Parker R.; McGregor J.; Beck A.; McClatchey M.W.

Vulvodynia: in situ hybridization analysis for human papillomavirus
pp. 152-152(1)
Authors: Gunter J.; Smith-King M.; Collins J.; Tawfik O.

The semi-quantitative assessment of menstrual flow in relation to clinical and hematological parameters
pp. 153-153(1)
Authors: Koudes P.A.; Phatak P.D.; Sham R.L.; Braggins C.; Cox C.; Howard F.

The substantial impact of von Willebrand disease on menstruation
pp. 153-154(2)
Authors: Kouides P.A.; Burkart P.; Phatak P.D.; Porter J.; Peacock L.; Braggins C.; Cox C.; Belling L.; Michalovic D.; Howard F.

Use of adenosine for pharmacological cardioversion of SVT in pregnancy
pp. 154-154(1)
Authors: Chakhtoura N.; Angioli R.; Yasin S.

The effects of cigarette smoking on pulmonary function tests during pregnancy
pp. 154-154(1)
Authors: Silverman R.K.; France L.

Normative oxygen saturation values for pregnant women at sea level
pp. 154-155(2)
Authors: Richlin S.; Cusick W.; Sullivan C.; Dildy G.; Belfort M.

Hemodynamic and hormonal changes during pneumoperitoneum and trendelenburg positioning for operative gynecologic laparoscopy surgery
pp. 155-155(1)
Authors: Stone J.; Dyke L.; Fritz P.; Reigle M.; Verrill H.; Bhakta K.; Boike G.; Graham J.; Gerbasi F.

Incidence, clinical characteristics, and timing of objectively diagnosed venous thromboembolism during pregnancy
pp. 155-156(2)
Authors: Gherman R.B.; Goodwin T.M.; Leung B.; Byrne J.D.; Montoro M.

Effect of oral contraceptives containing 20 and 35 g ethinyl estradiol on urinary prostacyclin and thromboxane levels in smokers and non-smokers
pp. 156-156(1)
Authors: Ploszaj S.; Thornton M.H.; Stanczyk F.Z.; Mishell D.R.

New reference levels for CA125 in pre- and postmenopausal women
pp. 157-157(1)
Authors: Nguyen H.N.; Jacobson A.; Patino-Paul R.

Management of Krukenberg tumors: an 11-year experience and review of the literature
pp. 157-158(2)
Authors: McGill F.; Ritter D.B.; Rickard C.; Kaleya R.N.; Wadler S.; Greston W.M.

Gene therapy of epithelial ovarian cancer using adenoviral vectors
pp. 158-158(1)
Author: Al-Hendy A.

Factors leading to delay in diagnosis of invasive cervical cancer
pp. 158-158(1)
Authors: Dworkin M.; Killackey M.; Johnson J.C.

Small cell carcinoma of the cervix: a clinical study of 15 patients and review of the literature
pp. 159-159(1)
Authors: Weed J.C.; Shoup B.; Tawfik O.

Endometrial carcinoma under the age of 40: reappraisal for oophorectomy in stage I disease
pp. 159-159(1)
Authors: Chen S.S.; Anderson A.

Primary malignant melanoma of the uterine cervix: case report and review of the literature
pp. 159-160(2)
Authors: Cantuaria G.; Angioli R.; Fernandez-Abril A.; Penalver M.

A randomized prospective study of the use of endometrial ablation for prevention of recurrent endometrial polyps in breast cancer patients receiving tamoxifen
pp. 160-160(1)
Authors: Goldenberg M.; Nezhat C.; Seidman D.S.

Positive margins after cervical conization as an indicator of residual dysplasia
pp. 160-161(2)
Authors: Huang M.; Anderson P.

Poor correlation of high-grade cervical dysplasia with referral cytology: clinical implications
pp. 161-161(1)
Authors: Lonky N.M.; Sadeghi M.; Tsadik G.W.

Evaluation of the cone biopsy excisor compared with the large loop for electrosurgical excision of cervical lesions
pp. 161-162(2)
Authors: Fischer N.R.; Alexandarian D.; Gagliardi S.; Oglesby J.; Scribner D.; Asuncion C.; Mesologitis T.

Potential hazards of following atypical and low-grade cervical cytology without colposcopy
pp. 162-162(1)
Authors: Nyirjesy I.; Billingsley F.S.

Neural network-assisted (''NNA'') analysis of cervical smears: pooled effectiveness results and economic analysis
pp. 162-163(2)
Authors: Mango L.J.; Radensky P.

Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for the detection of abnormal cervical lesions: systematic review and meta-analysis
pp. 163-163(1)
Authors: Allen I.E.; Connelly J.; Luo D.; Ross S.D.

ThinPrep cytology in clinical practice
pp. 163-163(1)
Authors: Sedlacek T.V.; Edmonds P.R.

A large-scale investigator-sponsored field study of the test performance of the ThinPrep papanicolaou test in a low-risk routine outpatient setting
pp. 164-164(1)
Authors: Weintraub J.; Wenger D.

Diagnosis of invasive cervical carcinoma with fluid-based, thin-layer slide preparation method
pp. 164-164(1)
Authors: Inhorn S.L.; Linder J.; Wilbur D.C.; Zahniser D.

Postmenopausal hormone replacement and obesity
pp. 165-165(1)
Authors: Pearce K.F.; Reboussin D.M.; Mayer-Davis E.; Ephross S.; Burke G.L.

Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis
pp. 165-165(1)
Authors: Nanda K.; Bastian L.A.; Hasselblad V.; Simel D.L.

Clinically favorable effects of raloxifene on bone mineral density and serum lipids: population assessment via bivariate analysis
pp. 165-166(2)
Authors: Shah A.; Iversen P.; Mitlak B.

Raloxifene effects on vasomotor and other climacteric symptoms in postmenopausal women
pp. 166-166(1)
Authors: Glusman J.E.; Huster W.J.; Paul S.

Raloxifene HCl is not stimulatory in the endometrium as assessed by the blaustein criteria and an estrogenicity scoring system
pp. 167-167(1)
Authors: Shah A.S.; Scheele W.H.; Glant M.D.; Fugere P.

Pregnancy rates following hysteroscopic polypectomy, myomectomy, and a normal cavity in infertile patients
pp. 168-168(1)
Authors: Keltz M.; Varasteh N.; Levin B.; Neuwirth R.

Tubal surgery vs in vitro fertilization for the treatment of infertility due to distal tubal occlusion
pp. 168-168(1)
Authors: Nichols K.P.; Steinkampf M.P.

Outcome of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) using human sperm prepared via a new standardized swim-up technique fit for office use
pp. 169-169(1)
Authors: Zarmakoupis-Zavos P.N.; Correa J.R.; Clark W.; Zavos P.M.

The effects of in vitro fertilization on subsequent pregnancy outcome
pp. 169-169(1)
Authors: Silverman R.K.; Wojtowycz M.

Human motile sperm recovery after cryopreservation: freezing in nitrogen vapor vs the direct plunge technique
pp. 170-170(1)
Authors: Ziegler W.F.; Chapitis J.

Viability of human semen specimens cryostored and transported at 5 C using the Bio-Tranz&unknown; shipping system
pp. 170-171(2)
Authors: Zavos P.M.; Correa J.R.; Rodriguez F.; Zarmakoupis-Zavos P.N.

Depo-provera: an excellent contraceptive for those who continue to use it
pp. 172-172(1)
Authors: Rosser M.; Stone J.; Graves W.; Hatcher R.

Experience and acceptability of emergency hormonal contraception
pp. 172-172(1)
Authors: Hakim-Elahi E.; Breitbart V.

Differences in contraceptive methods used by women with physical disabilities compared to women without disabilities
pp. 172-173(2)
Authors: Nosek M.A.; Wuermser L.-A.; Walter L.J.

A multicenter, randomized comparative trial of the clinical effects on cycle control of two 21-day regimens of oral contraceptives containing 20 g EE
pp. 173-173(1)
Authors: Del Conte A.; Loffer F.; Grubb G.

The tolerability of a triphasic norgestimate/EE-containing OC: results from a double-blind, placebo-controlled trial
pp. 173-174(2)
Authors: Lippman J.S.; Godwin A.; Olson W.

An analysis of risk factors associated with blood transfusion in ectopic pregnancy
pp. 175-175(1)
Authors: Hendrix N.W.; Chauhan S.P.; Mobley J.; Devoe L.D.; Smith R.P.

Management of separation pain after single-dose methotrexate therapy for ectopic pregnancy
pp. 175-175(1)
Authors: Lipscomb G.H.; Puckett K.J.; Bran D.; Ling F.W.

Intravaginal misoprostol for medical evacuation of first trimester missed abortion
pp. 176-176(1)
Authors: Wakabayashi M.; Tretiak M.; Kosasa T.; Sharma S.; Aeby T.; Kamemoto L.; Diniega L.

Misoprostol in second trimester termination of pregnancy
pp. 176-176(1)
Authors: Wright-Francis D.L.; Raynor B.D.; Webb G.W.

Lack of prenatal care increases the rate of recurrent preterm delivery and health care costs when compared to university hospital-based prenatal care
pp. 177-177(1)
Authors: Ural S.; Cox C.; Blakemore K.; Pressman E.; Bienstock J.

Safety and cost-effectiveness of managing patients at risk for immediate preterm delivery on a minimum care unit
pp. 177-177(1)
Authors: Soper D.E.; Brown S.; VanDorsten J.P.

The safety and efficacy of prolonged outpatient sulindac to prevent the recurrence of preterm labor: a prospective double-blind study
pp. 178-178(1)
Authors: Bartfield M.; Carlan S.J.

Term delivery after hospitalization for preterm labor: incidence and costs in california
pp. 178-178(1)
Authors: Grover C.M.; Posner S.; Kupperman M.; Washington E.A.

Use of the fetal fibronectin assay to avert unnecessary hospitalization and bedrest in patients with preterm labor symptoms: a cost analysis
pp. 178-179(2)
Author: Grover C.M.

Fetal fibronectin in symptomatic twin gestations
pp. 179-179(1)
Authors: Terrone D.A.; Rinehart B.K.; Kraeden U.; Morrison J.C.

A meta-analysis of salivary estriol (sE₃) as a means to identify women at risk for preterm birth due to fetal-placental endocrine mechanisms
pp. 179-179(1)
Authors: McGregor J.A.; Hastings C.; Dullien V.

Perinatal outcome of triplet gestation: does prophylactic cerclage make a difference?
pp. 180-180(1)
Authors: Elimian A.; Figueroa R.; Nigam S.; Verma U.; Tejani N.; Kirshenbaum N.

Effects of magnesium sulfate tocolysis on maternal mental status
pp. 180-180(1)
Authors: Zinnante M.; Meyer G.G.; Meyer B.A.

Risk factors in premature rupture of membranes
pp. 181-181(1)
Authors: Silverman R.K.; Wojtowycz M.

Preterm premature rupture of the membranes is associated with asymmetric intrauterine growth retardation and smaller placentas
pp. 181-181(1)
Authors: Kurzel R.B.; Lampley E.C.

A randomized trial comparing prostaglandin E₂ vaginal insert (Cervidil) to vaginal gel for cervical ripening before induction of labor
pp. 182-182(1)
Authors: Veligati P.; Broekhuizen F.F.; Kirby R.S.; Malnory M.

Comparative cost analysis of prostaglandin analogues dinoprostone and misoprostol as labor preinduction agents
pp. 182-182(1)
Authors: Ramsey P.S.; Harris D.Y.; Ogburn P.L.; Heise R.H.; Magtibay P.M.; Ramin K.D.

Attempted vaginal birth after cesarean section: a multicenter comparison of outpatient prostaglandin E₂ gel with expectant management
pp. 182-183(2)
Authors: Rayburn W.; Lucas M.; Gittens L.; Goodwin T.M.; Baxi L.; Gall S.; Mostello D.; Heyl P.

Is induction of labor with continuous release dinoprostone vaginal pessary a viable option in patients with preeclampsia?
pp. 183-183(1)
Authors: Ascher-Walsh C.; Tharakan T.; Baxi L.

A randomized trial of vaginal prostaglandin E₂ gel and dinoprostone vaginal insert for induction of labor at term
pp. 183-183(1)
Authors: Sadaty A.; Pagano M.; Greer C.; Sison C.; Schaffir J.

Perinatal mortality and morbidity rates among singleton, twin, and triplet gestations
pp. 184-184(1)
Authors: Hedriana H.L.; Eby-Wilkens E.M.; Gilbert W.M.

Labor ward workload waxes and wanes with the lunar cycle, myth or reality?
pp. 184-184(1)
Authors: Joshi R.; Bharadwaj A.; Gallousis S.; Matthews R.

A comparison of laboratory data in perinatal transfers at Baystate Medical Center and transferring hospitals
pp. 184-185(2)
Authors: Yu C.; Cohn G.

Accuracy and intraobserver variability of simulated cervical dilatation and effacement measurements
pp. 185-185(1)
Authors: Phelps J.Y.; Lambrou N.; Roshanfekr D.

The frequency of extramembranous placement of intrauterine pressure catheters
pp. 185-185(1)
Author: Lind B.K.

Transverse arrest: a review of outcomes of rotational forceps and cesarean delivery at a single center
pp. 186-186(1)
Authors: Leo M.V.; Odibo A.; Ling P.Y.; Rodis J.; Borgida A.; Campbell W.

Outcome predictors for patients delivered by cesarean section for fetal distress
pp. 186-186(1)
Authors: Harrigan J.T.; Muscio L.

Elective cesarean hysterectomy vs elective cesarean section followed by remote hysterectomy: reassessing the risks
pp. 187-187(1)
Authors: Bost B.W.; Rising K.W.; Bost D.L.

Cesarean hysterectomy for placenta previa accreta, increta, and percreta: a strategic approach to minimize surgical hemorrhage
pp. 187-187(1)
Authors: Pelosi M.A.; Pelosi M.A.

Vaginal birth after cesarean delivery: a group practice's approach to minimizing failed trial of labor
pp. 187-188(2)
Authors: Stedman C.M.; Scudder S.R.; Joseph G.F.

Elective repeat cesarean delivery vs trial of labor: a comparison of morbidities in a community hospital setting
pp. 188-188(1)
Authors: Scott T.D.; Flora R.; Deveny T.C.

Home subcutaneous metochlopramide therapy for hyperemesis gravidarum
pp. 189-189(1)
Authors: Buttino L.; Gambon C.

Effects of gestational and overt diabetes on placental cytochromes P450 and glutathione S-transferase
pp. 189-189(1)
Authors: Glover D.D.; McRobie D.J.; Tracy T.S.

Combining human placental lactogen with routine glucose challenge tests
pp. 189-190(2)
Authors: Henderson C.E.; Divon M.Y.

Screening for gestational diabetes mellitus in adolescent Hispanics
pp. 190-190(1)
Authors: Southwick R.D.; Wigton T.R.

Monitoring birth outcomes in the Sumatriptan Pregnancy Registry
pp. 190-190(1)
Authors: Eldridge R.R.; Ephross S.A.

Monitoring pregnancy outcomes following prenatal drug exposure through prospective pregnancy registries and passive surveillance: a pharmaceutical company commitment
pp. 190-191(2)
Authors: Eldridge R.R.; Ephross S.A.; Heffner C.R.; Tennis P.S.; Stender D.M.; White A.D.

Acute fatty liver in the second trimester of pregnancy
pp. 191-191(1)
Authors: Monga M.; Katz A.R.

Acute fatty liver of pregnancy: an experience in diagnosis and management of eight cases
pp. 191-191(1)
Authors: Ynag W.; Shen Z.

Abdominal pregnancy: to remove or not to remove the placenta
pp. 192-192(1)
Authors: Mekki Y.; Gilles J.M.; Mendez L.; O'Sullivan M.J.

Comparison of the accuracy of gestational age estimation from fetal heart rate and crown-rump length
pp. 193-193(1)
Authors: Tezuka N.; Saito H.; Hiroi M.

Correlation of maternal triple screen values with fetal liver length
pp. 193-193(1)
Authors: Duhl A.; Donnenfeld A.; Palomaki G.

Accurate prediction of term birth weight from prospectively measurable maternal characteristics
pp. 193-194(2)
Authors: Nahum G.G.; Stanislaw H.; Huffaker B.J.

Hysterosonography as an adjunct to transvaginal sonography in the evaluation of intraluminal lesions of the uterine cavity
pp. 194-194(1)
Authors: Im D.D.; Murphy C.A.; Rosenshein N.B.

Experience with collaborative management of symptomatic fibroids by gynecology and interventional radiology
pp. 194-194(1)
Authors: Hutchins F.L.; Worthington-Kirsch R.L.

Polysomnographic characteristics of sleep disorders in chronic pelvic pain
pp. 195-195(1)
Authors: Dunlap K.T.; Yu L.; Fisch B.J.; Nolan T.E.

A food interaction study of bromfenac, naproxen sodium, and placebo in cesarean section patients
pp. 195-195(1)
Authors: Sunshine A.; Olson N.Z.; Zighelboim I.; Wajdula J.S.

Comparison of bromfenac and naproxen sodium in the management of primary dysmenorrhea
pp. 195-195(1)
Author: Mehlisch D.R.

Effect of lidocaine vs ketorolac tromethamine on postoperative laparoscopy pain control: a randomized study
pp. 196-196(1)
Authors: David A.M.; Swanson M.L.; Leve C.M.; Johnson J.P.; Dubin N.H.

A randomized, placebo-controlled comparison of EMLA^&unknown; and dorsal penile nerve block for pain relief during neonatal circumcision
pp. 196-196(1)
Authors: Howard F.M.; Howard C.R.; Fortune K.; Generelli P.; Zolnoun D.; tenHoopen C.

Are the long-term adverse effects of laparoscopic presacral neurectomy for the management of central pain associated with endometriosis acceptable?
pp. 197-197(1)
Authors: Nezhat C.H.; Seidman D.S.; Nezhat F.; Nezhat C.

Epidural anesthesia performed during labor by obstetricians: outcome analysis
pp. 197-197(1)
Authors: Kemmerly J.R.; Lambard W.W.; Russell R.C.

A randomized blinded trial of preemptive local anesthesia in laparoscopy
pp. 197-198(2)
Authors: Ke R.W.; Portera S.G.; Lincoln S.R.

A prospective randomized trial of the use of epidural anesthesia during external cephalic version
pp. 198-198(1)
Authors: Mancuso K.; Yancey M.K.; Murphy J.A.; Daniels D.; Markenson G.

The ''Femassist'': a new device for the treatment of female urinary incontinence
pp. 199-199(1)
Author: Rabin J.M.

The outpatient Closed Burch-M.M. procedure for treatment of genuine stress urinary incontinence with no laparotomy or laparoscopy by newly invented bladder saver device
pp. 199-199(1)
Author: Samimi D.

Vaginal paravaginal repair in the surgical treatment of anterior vaginal wall prolapse
pp. 199-200(2)
Authors: Mallipeddi P.; Kohli N.; Steele A.C.; Owens R.G.; Karram M.M.

Laparoscopic ureteroureterostomy: a prospective follow-up of 9 patients
pp. 200-200(1)
Authors: Nezhat C.H.; Nezhat F.; Seidman D.; Nezhat C.

Long-term urodynamic evaluation of a continent urinary reservoir
pp. 200-200(1)
Authors: Lynch C.M.; Towsley G.A.; Pow-Sang J.M.; Seigne J.D.; Lockhart J.L.

Abdominal sacral colpopexy for massive genital prolapse
pp. 201-201(1)
Authors: Powell J.L.; Joseph D.B.

Risk of complications following gynecological laparoscopic surgery
pp. 202-202(1)
Authors: Mirhashemi R.; Harlow B.L.; Ginsberg E.; Signorello L.B.; Berkowitz R.; Feldman S.

Risk adjustment for complications of hysterectomy: utility of routinely collected administrative data
pp. 202-203(2)
Authors: Meyers E.R.; Steege J.F.

Functional outcomes and satisfaction after abdominal hysterectomy
pp. 203-203(1)
Authors: Weber A.M.; Walters M.D.; Schover L.R.; Church J.M.; Piedmonte M.R.

Hysterectomy in a decade of change: more than a weighty matter
pp. 203-204(2)
Authors: Kirk J.H.; Karlan B.Y.; Cane P.; Gregory K.

Prediction of endometrial ablation success by preoperative findings
pp. 204-204(1)
Authors: Ziegler W.F.; Sites C.; Badger G.; Shamonki M.

Intraoperative blood loss and gestational age at pregnancy termination
pp. 204-205(2)
Authors: Marchiano D.A.; Thomas A.G.; Lapinski R.; Balwan K.; Patel J.

Clinical outcomes of OPERA, out-patient endometrial resection/ablation
pp. 205-205(1)
Author: Kresch A.

Clinical experience with the ^OPERAStarSL using saline irrigation fluid for OPERA
pp. 205-206(2)
Authors: Feste J.R.; Lotze E.C.

The BirthPlace collaborative practice model: results from the San Diego Birth Center Study
pp. 207-207(1)
Authors: Swartz W.; Jackson D.; Lang J.; Ecker J.; Ganiats T.; Dickinson C.; Nguyen U.-s.

The use of midwives as first assistants in cesarean section
pp. 207-208(2)
Authors: Marks F.; Thacher F.; Camargo M.

The impact of prenatal care coordination on birth outcome
pp. 208-208(1)
Authors: Garry M.F.; Brown H.L.; Abernathy M.P.; Brown B.W.

Cost consequences of implementation of an early obstetrical discharge program in a military teaching hospital
pp. 208-208(1)
Authors: Calhoun B.C.; Gries D.; Barfield W.; Hume R.F.

Applying no-fault compensation criteria to obstetric malpractice claims
pp. 208-209(2)
Authors: Saphier C.J.; Thomas E.J.; Studdert D.; Brennan T.A.; Acker D.

The evaluation of the health care needs of women with disabilities
pp. 210-210(1)
Authors: Weppner D.M.; Brownscheidle C.M.

A multicenter randomized trial of DIAC for cyclical mastopathy
pp. 211-211(1)
Authors: Ballagh S.A.; Stover T.L.; Maragos T.G.; Reynolds M.D.; Wolfley G.D.; Esserman L.J.; Herbst J.R.; Kirkegaard L.W.; Teichman S.L.